Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Combined with Etoposide and Cytarabine in the Treatment of Newly Diagnosed Acute Myelomonocytic Leukemia or Acute Monocytic Leukemia

被引：0
|
作者：
Xue, Hua [1 ]
Guo, Huimei [1 ]
Ye, Shaojie [1 ]
Wang, Jing [1 ]
Zhao, Songying [1 ]
Xu, Jianmei [1 ]
Zhang, Jiangbo [1 ]
Liu, Jia [1 ]
Liu, Yao [2 ]
机构：
[1] Hebei Univ, Affiliated Hosp, Baoding, Peoples R China
[2] Chongqing Univ, Canc Hosp, Chongqing, Peoples R China
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-201895
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6033 / 6034
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of mitoxantrone, etoposide, and cytarabine for treatment of relapsed or refractory acute myeloid leukemia
    Zhong, Sharon
    Kurish, Heena
    Walchack, Robert
    Li, Hong
    Edwards, Jessi
    Singh, Abhay
    Advani, Anjali
    LEUKEMIA RESEARCH, 2024, 139
  • [2] MITOXANTRONE, ETOPOSIDE AND CYTARABINE IN THE TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA
    BJORKHOLM, M
    BJORNSDOTTIR, J
    STENKE, L
    GRIMFORS, G
    ONCOLOGY, 1990, 47 (02) : 112 - 114
  • [3] Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin
    McHayleh, Wassim
    Sehgal, Rajesh
    Redner, Robert L.
    Raptis, Anastasios
    Agha, Mounzer
    Natale, James
    Luong, The Minh
    Schlesselman, James J.
    Foon, Kennteh A.
    Boyiadzis, Michael
    LEUKEMIA & LYMPHOMA, 2009, 50 (11) : 1848 - 1853
  • [4] Etoposide and mitoxantrone in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy with cytarabine and idarubicin
    McHayleh, W. M.
    Redner, R.
    Sehgal, R.
    Raptis, A.
    Agha, M.
    Natale, J.
    Luong, T.
    Schlesselman, J. J.
    Foon, K.
    Boyiadzis, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine
    Estey, E
    Thall, PF
    Pierce, S
    Kantarjian, H
    Keating, M
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 483 - 490
  • [6] Efficacy and Safety of Decitabine Combined with IA Regimen in the Treatment of Newly Diagnosed Acute Myeloid Leukemia
    Kuang, Lifen
    Li, Juan
    BLOOD, 2021, 138
  • [7] MITOXANTRONE IN COMBINATION WITH ETOPOSIDE AND CYTARABINE FOR TREATMENT OF POOR PROGNOSIS ACUTE NONLYMPHOID LEUKEMIA PATIENTS
    TRIBALTO, M
    CANTONETTI, M
    CATALANO, G
    DELPOETA, G
    PASTORE, MMS
    PISANI, F
    STASI, R
    PAPA, G
    HAEMATOLOGICA, 1991, 76 (05) : 402 - 405
  • [8] Efficacy and safety of mitoxantrone and etoposide (ME) in refractory and relapsed acute nonlymphocytic leukemia
    Pourtsidis, AG
    Baka, M
    Stasinopoulou, A
    Varvoutsi, M
    Paidoussi, C
    Bouhoutsou, D
    Kosmidis, HV
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1998, 5 (01): : 7 - 11
  • [9] ACUTE MONOCYTIC LEUKEMIA AND MYELOMONOCYTIC LEUKEMIA - THEIR TREATMENT BY VP-16213
    AMIEL, JL
    SCHWARZENBERG, L
    MUSSET, M
    DEVASSAL, F
    HAYAT, M
    MATHE, G
    BULLETIN DU CANCER, 1974, 61 (03) : 419 - 426
  • [10] Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemia
    Liedtke, Michaela
    Dunn, Tamara
    Dinner, Shira
    Coutre, Steven E.
    Berubea, Caroline
    Gotlib, Jason
    Patel, Samit
    Medeiros, Bruno
    LEUKEMIA RESEARCH, 2014, 38 (12) : 1441 - 1445
12345